Nystatin Articles
Novartis' Reclast approved by US FDA
20 August 2007
Oramed completes Ph Ia with oral insulin gel caps
20 August 2007
Barr's second-qtr 2007 profit halves to $45.3M
20 August 2007
Cytogen's 2nd-qtr net loss widens to $10.4M
20 August 2007
Cytopia's Ph I CYT997 achieves primary objectives
13 August 2007
Ardana begins US study of ARD-07
13 August 2007
Oramed closes $2 million financing
13 August 2007
Tykerb side effects are "manageable," study
13 August 2007
Cephalon's 2nd-qtr 2007 sales hit $435M
13 August 2007
Austria funds routine rotavirus vaccination of infants
6 August 2007
Actavis launches Griseofulvin in USA
6 August 2007
Par licenses US rights to Hana's Zensana for up to $50M
6 August 2007
Singapore OKs OraQuick HIV test kit
6 August 2007
Dosing initiated in Ph III balaglitazone trial
6 August 2007
Crestor boosts Shionogi 1st-qtr fiscal sales 8.7%
6 August 2007
Wyeth's Lybrel now on sale in USA
6 August 2007
Akorn signs 10-year supply deal with Cipla
30 July 2007
ChemoCentryx gains $5M milestone from GSK
30 July 2007
CHMP recommends approval Exelon patch
30 July 2007
Hi-Tech licenses asthma drug from Biomarin
23 July 2007
SMC OKs Lilly's Byetta as insulin alternative
23 July 2007
Strong early Ph I data for Amira's AM103
23 July 2007
Centrix to manufacture and supply Cedar's Northyx
23 July 2007
Rotateq/Gardasil on all US VFC programs
23 July 2007
Japan stock market week to July 16, 2007
23 July 2007
Merck & Co pays NicOx SA $6.8M milestone
23 July 2007
FDA accepts Collegium's opioid product IND
23 July 2007
Novacea gets $60M payment for S-P under Asentar deal
16 July 2007
Yaz approved in the Netherlands
16 July 2007
Generex announces Armenian Oral-lyn deal
16 July 2007
Boeh Ing's dabigatran as effective as enoxaparin
16 July 2007
BioCryst agrees SPA for pivotal oral Fodosine trial
16 July 2007
B-MS/Pfizer anti-clotting drug shows promise
16 July 2007
SuperGen/TGen dose Ph I MP470 study
16 July 2007
Canada clears Seasonale OC
16 July 2007
Rifamycin MMX impresses at Ph II/III
16 July 2007
US FDA approves generic Lamisil
9 July 2007
Shire submits sNDA for Vyvanse to US FDA
9 July 2007
CellCept falls short in Phase III trial
9 July 2007
Zila's 3rd-qtr fiscal 2007 loss reduced
2 July 2007
Roche licenses Toyama's Ph I RA drug for $370M
2 July 2007
US FDA approves Sigma-Tau
2 July 2007
Acadia initiates Ph IIb trial of ACP-104
2 July 2007
Reassuring CV safety from Ph IIIb Cycloset trial
2 July 2007
US scripts of GSK's Avandia continue to fall
2 July 2007
France's LEEM launches orphan drug campaign
2 July 2007
Liraglutide gives better control than Lantus
2 July 2007
Stock Commentary - Europe - week to June 18, 2007
25 June 2007
Anadys nominates ANA598 for development
25 June 2007
Surface Logix begins trial of SLx-2101
25 June 2007
EC clears Celgene's Revlimid for MM
25 June 2007
Bradley Pharma debuts Elestrin in USA
18 June 2007
B-MS pleads guilty in Plavix antitrust case
18 June 2007
Immtech licenses pafuramidine to Par
18 June 2007
Strong Ph III data for Revolade in chronic ITP
18 June 2007
Need for drugs to tackle "superbugs"
18 June 2007
Repligen narrows loss 87% in fiscal 4th-qtr
18 June 2007
Toray seeks approval of Feron plus ribavirin
18 June 2007
Bayer to showcase health care business to analysts
18 June 2007
Lilly reports benefits of Alimta in NSCLC
11 June 2007
EntreMed's ENMD-981693 shows preclinical promise
11 June 2007
Talima raises $19M in series B funding round
4 June 2007
Activist group releases Gardasil AE data
4 June 2007
Japan's Sosei initiates Ph I with SD118
4 June 2007
Orphan status for Phoqus' Chronocort
4 June 2007
Vanda's iloperidone shows good akathisia profile
4 June 2007
BioMarin files NDA in USA for Kuvan
28 May 2007
Ph IIIa NOMAC/E2 trial completes recruitment
28 May 2007
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
